Claus Crone Fuglsang
Tracked across 1 events · 6 articles · First seen Aug 10, 2026 · Last active Aug 10, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
On August 10, Novonesis, a Copenhagen-based biotechnology company, announced it has signed an agreement to acquire the remaining shares of MicroBioGen, an Australian biotechnology firm specializing in yeast strains for industrial applications, particularly bioethanol. This…
Impact: As Chief Scientific Officer, Claus Crone Fuglsang supports the integration of MicroBioGen's technology, enhancing Novonesis' R&D capabilities.
Aug 10, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Claus Crone Fuglsang live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard